KROS
Keros Therapeutics, Inc. Healthcare - Biotechnology Investor Relations →
Keros Therapeutics, Inc. (KROS) closed at $17.57 as of 2026-02-02, trading 52.0% below its 200-week moving average of $36.58. This places KROS in the extreme value zone. The stock is currently moving closer to the line, down from -51.4% last week. The 14-week RSI sits at 58, indicating neutral momentum.
Over the past 256 weeks of data, KROS has crossed below its 200-week moving average 12 times. On average, these episodes lasted 14 weeks. The average one-year return after crossing below was -21.7%, suggesting these dips have not historically been reliable buying opportunities for this stock.
With a market cap of $535 million, KROS is a small-cap stock. The company generates a free cash flow yield of 9.2%, which is notably high. Return on equity stands at 10.4%. The stock trades at 1.0x book value.
Share count has increased 69.2% over three years, indicating dilution. This stock also meets the Yartseva multibagger criteria as a small-cap with strong free cash flow yield and reasonable book value.
Over the past 5 years, a hypothetical investment of $100 in KROS would have grown to $30, compared to $187 for the S&P 500. KROS has returned -21.5% annualized vs 13.3% for the index, underperforming the broader market over this period.
Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: KROS vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After KROS Crosses Below the Line?
Across 12 historical episodes, buying KROS when it crossed below its 200-week moving average produced an average return of -14.6% after 12 months (median -17.0%), compared to +11.8% for the S&P 500 over the same periods. 42% of those episodes were profitable after one year. After 24 months, the average return was -18.5% vs +30.6% for the index.
Each line shows $100 invested at the moment KROS crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
KROS has crossed below its 200-week MA 12 times with an average 1-year return of +-21.7% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 2021 | Jun 2021 | 4 | 6.6% | -10.0% | -64.0% |
| Jun 2021 | Nov 2021 | 19 | 36.1% | -36.4% | -60.9% |
| Jan 2022 | Feb 2022 | 3 | 12.8% | +9.2% | -62.1% |
| May 2022 | Oct 2022 | 25 | 43.1% | -7.3% | -63.1% |
| Nov 2022 | Nov 2022 | 2 | 1.2% | -35.8% | -61.9% |
| Dec 2022 | Dec 2022 | 1 | 0.0% | -18.2% | -62.4% |
| Mar 2023 | May 2023 | 10 | 17.3% | +59.2% | -60.3% |
| Jun 2023 | Jan 2024 | 30 | 39.5% | +10.9% | -60.0% |
| May 2024 | Jun 2024 | 1 | 2.0% | -69.8% | -62.5% |
| Jun 2024 | Jul 2024 | 4 | 11.8% | -71.0% | -62.2% |
| Aug 2024 | Sep 2024 | 4 | 5.5% | -69.7% | -61.3% |
| Dec 2024 | Ongoing | 61+ | 77.0% | Ongoing | -6.7% |
| Average | 14 | — | +-21.7% | — |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02